Fundraising Fox

Conkwest

NASDAQ: IBRX

Cardiff-By-The-Sea, US · Delaware corporation

Biotech

Founders & leadership

RG
Richard GombergExecutive
BS
Barry SimonExecutive
SG
Steven GorlinNamed on SEC filing
HG
Hans G. KlingemannNamed on SEC filing

Board

HJ
Henry JiBoard director
JT
John ThomasBoard director
PS
Patrick Soon-ShiongBoard director
RK
Richard KusserowBoard director
RR
Robert RosenBoard director
JP
John PottsBoard director

Reported raises · per SEC filings

Form D private placements

$639.6M disclosed across 7 rounds · 2014–2023

▶$470MraisedSep 2023 · 3 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Patrick Soon-ShiongExecutive Officer, Director
  • Cheryl CohenDirector
  • Linda MaxwellDirector
  • Michael BlaszykDirector
  • Wesley ClarkDirector
  • Richard AdcockExecutive Officer, Director
  • Barry SimonDirector
  • John BrennanDirector
  • David SachsExecutive Officer
  • Christobel SeleckyDirector
Offering amount
$470M
Amount sold
$470M
Sales commissions
$1M
First sale
Sep 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$10.7MraisedJul 2022 · 6 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Michael BlaszykDirector
  • Barry SimonDirector
  • Christobel SeleckyDirector
  • John BrennanDirector
  • Wesley ClarkDirector
  • Linda MaxwellDirector
  • Richard AdcockExecutive Officer, Director
  • Patrick Soon-ShiongExecutive Officer, Director
  • David SachsExecutive Officer
  • Cheryl CohenDirector
Offering amount
$10.7M
Amount sold
$10.7M
First sale
Jul 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$17MraisedAug 2015 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • John T. Potts, Jr., M.D.Director
  • Henry Ji, Ph.D.Director
  • John C. Thomas, Jr.Director
  • Richard GombergExecutive Officer
  • Barry J. Simon, M.D.Executive Officer, Director
  • Steve GorlinDirector
  • Robert RosenDirector
  • Michael BlaszykDirector
  • Richard KusserowDirector
  • Patrick Soon-Shiong, M.D.Executive Officer, Director
Offering amount
$17M
Amount sold
$17M
First sale
Jul 2015
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$78MraisedJul 2015 · 11 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Steve GorlinDirector
  • Patrick Soon-Shiong, M.D.Executive Officer, Director
  • Barry J. Simon, M.D.Executive Officer, Director
  • Henry Ji, Ph.D.Director
  • John T. Potts, Jr., M.D.Director
  • Hans Klingemann, M.D., Ph.D.Director
  • Richard GombergExecutive Officer
  • Richard KusserowDirector
  • John C. Thomas, Jr.Director
  • Robert RosenDirector
Offering amount
$78M
Amount sold
$78M
First sale
Jun 2015
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$47.5MraisedJan 2015 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Henry JiDirector
  • Richard KusserowDirector
  • John ThomasDirector
  • Richard GombergExecutive Officer
  • Patrick Soon-ShiongDirector
  • Barry SimonExecutive Officer, Director
  • Steven GorlinDirector
  • Hans G. KlingemannDirector
  • Robert RosenDirector
  • John PottsDirector
Offering amount
$47.5M
Amount sold
$47.5M
First sale
Dec 2014
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$10MraisedDec 2014 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Steven GorlinDirector
  • Hans G. KlingemannDirector
  • John ThomasDirector
  • Barry SimonExecutive Officer, Director
  • Robert RosenDirector
  • Richard KusserowDirector
  • Patrick Soon-ShiongDirector
  • Richard GombergExecutive Officer
  • Henry JiDirector
  • John PottsDirector
Offering amount
$10M
Amount sold
$10M
First sale
Dec 2014
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$6.5MraisedApr 2014 · 48 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Hans KlingemannDirector
  • Barry SimonExecutive Officer, Director
Offering amount
$9.6M
Amount sold
$6.5M
Minimum investment
$5K
Sales commissions
$518.7K
Placement agents
Palladium Capital Advisors, LLC
First sale
Apr 2014
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Dr. Soon-Shiong's CAR-T IPO NantKwest - Nanalyzenanalyze.com · Jul 2015Conkwest aims to plunder $173m in IPO -globalventuring.com · Jun 2015CONK.RC IPO News - Natural born cancer killers: Conkwest files for a $173 million IPOrenaissancecapital.com · Jun 2015SRNE: NantWorks and Sorrento Invest $50 Million into Conkwest and Dr. Patrick Soon-Shiong is Appointed as Co-Chairman Of The Boardfinance.yahoo.com · Dec 2014Conkwest Announces $50m In Strategic Investments And Appoints NantWorks Founder, Dr. Patrick Soon-Shiong As Co-Chairman Of The Boardprnewswire.com · Dec 2014

Frequently asked questions

How much funding has Conkwest raised?
Conkwest has disclosed $639.6M raised across 7 rounds.
Where is Conkwest headquartered?
Conkwest is headquartered in Cardiff-By-The-Sea, US.